BR112018002140A2 - USO DE MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR ASGRAVIDADES DAS INFECÇÕES RESPIRATÓRIAS POR VÍRUS RESPIRATÓRIO SINCITIAL E METAPNEUMOVÍRUS HUMANO - Google Patents
USO DE MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR ASGRAVIDADES DAS INFECÇÕES RESPIRATÓRIAS POR VÍRUS RESPIRATÓRIO SINCITIAL E METAPNEUMOVÍRUS HUMANOInfo
- Publication number
- BR112018002140A2 BR112018002140A2 BR112018002140A BR112018002140A BR112018002140A2 BR 112018002140 A2 BR112018002140 A2 BR 112018002140A2 BR 112018002140 A BR112018002140 A BR 112018002140A BR 112018002140 A BR112018002140 A BR 112018002140A BR 112018002140 A2 BR112018002140 A2 BR 112018002140A2
- Authority
- BR
- Brazil
- Prior art keywords
- respiratory
- sincitial
- molecular markers
- characterize
- human metapneumovirus
- Prior art date
Links
- 241000342334 Human metapneumovirus Species 0.000 title 1
- 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 title 1
- 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 title 1
- 108010002386 Interleukin-3 Proteins 0.000 title 1
- 108010067003 Interleukin-33 Proteins 0.000 title 1
- 206010057190 Respiratory tract infections Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5403—IL-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5434—IL-12
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL201502153 | 2015-07-31 | ||
| CL2015002153A CL2015002153A1 (es) | 2015-07-31 | 2015-07-31 | Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano |
| PCT/IB2016/054423 WO2017021814A1 (en) | 2015-07-31 | 2016-07-25 | Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018002140A2 true BR112018002140A2 (pt) | 2018-09-11 |
| BR112018002140B1 BR112018002140B1 (pt) | 2024-01-23 |
Family
ID=56081023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018002140-7A BR112018002140B1 (pt) | 2015-07-31 | 2016-07-25 | Uso de marcadores moleculares il-3, il-33 e il-12p40 para caracterizar as gravidades das infecções respiratórias por vírus respiratório sincitial e metapneumovírus humano |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11085080B2 (pt) |
| EP (1) | EP3329019B1 (pt) |
| KR (1) | KR102621463B1 (pt) |
| CN (1) | CN108368556B (pt) |
| AR (1) | AR105542A1 (pt) |
| BR (1) | BR112018002140B1 (pt) |
| CA (1) | CA2994252A1 (pt) |
| CL (1) | CL2015002153A1 (pt) |
| CO (1) | CO2018001917A2 (pt) |
| ES (1) | ES2783859T3 (pt) |
| MX (1) | MX2018001373A (pt) |
| PE (1) | PE20180577A1 (pt) |
| PT (1) | PT3329019T (pt) |
| RU (1) | RU2707549C2 (pt) |
| UY (1) | UY36819A (pt) |
| WO (1) | WO2017021814A1 (pt) |
| ZA (1) | ZA201800940B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3218515B1 (en) | 2014-11-10 | 2023-04-26 | F. Hoffmann-La Roche AG | Therapeutic and diagnostic methods for il-33-mediated disorders |
| CR20170240A (es) | 2014-11-10 | 2018-04-03 | Genentech Inc | Anticuerpos anti-interleucina-33 y sus usos |
| WO2021183849A1 (en) | 2020-03-13 | 2021-09-16 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
| JP6960642B2 (ja) * | 2020-04-16 | 2021-11-05 | 国立研究開発法人国立国際医療研究センター | 呼吸器感染症の重症化の予測を補助する方法、バイオマーカーの測定値をモニタリングする方法、これらの方法に用いられる試薬キット、呼吸器感染症の重症化の予測を補助する装置およびコンピュータプログラム |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531890A (ja) | 2007-06-26 | 2010-09-30 | メディミューン，エルエルシー | Ｒｓｖ感染症及び関連する症状の治療方法 |
| KR101286463B1 (ko) * | 2011-01-28 | 2013-07-16 | 환인제약 주식회사 | 천궁 추출물을 함유하는 호흡기 질환의 예방 또는 치료용 조성물 |
-
2015
- 2015-07-31 CL CL2015002153A patent/CL2015002153A1/es unknown
-
2016
- 2016-07-25 CN CN201680052892.7A patent/CN108368556B/zh active Active
- 2016-07-25 KR KR1020187005531A patent/KR102621463B1/ko active IP Right Grant
- 2016-07-25 ES ES16832386T patent/ES2783859T3/es active Active
- 2016-07-25 RU RU2018104707A patent/RU2707549C2/ru active
- 2016-07-25 BR BR112018002140-7A patent/BR112018002140B1/pt active IP Right Grant
- 2016-07-25 US US15/748,984 patent/US11085080B2/en active Active
- 2016-07-25 CA CA2994252A patent/CA2994252A1/en active Pending
- 2016-07-25 MX MX2018001373A patent/MX2018001373A/es unknown
- 2016-07-25 PE PE2018000146A patent/PE20180577A1/es unknown
- 2016-07-25 EP EP16832386.3A patent/EP3329019B1/en active Active
- 2016-07-25 PT PT168323863T patent/PT3329019T/pt unknown
- 2016-07-25 WO PCT/IB2016/054423 patent/WO2017021814A1/en active Application Filing
- 2016-07-27 UY UY0001036819A patent/UY36819A/es not_active Application Discontinuation
- 2016-07-29 AR ARP160102327A patent/AR105542A1/es unknown
-
2018
- 2018-02-12 ZA ZA2018/00940A patent/ZA201800940B/en unknown
- 2018-02-22 CO CONC2018/0001917A patent/CO2018001917A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3329019B1 (en) | 2020-01-01 |
| UY36819A (es) | 2017-01-31 |
| KR20180028525A (ko) | 2018-03-16 |
| ES2783859T3 (es) | 2020-09-18 |
| PT3329019T (pt) | 2020-04-08 |
| CO2018001917A2 (es) | 2018-05-10 |
| US11085080B2 (en) | 2021-08-10 |
| CL2015002153A1 (es) | 2016-01-29 |
| KR102621463B1 (ko) | 2024-01-04 |
| CN108368556B (zh) | 2021-06-22 |
| EP3329019A1 (en) | 2018-06-06 |
| RU2018104707A3 (pt) | 2019-08-28 |
| CA2994252A1 (en) | 2017-02-09 |
| ZA201800940B (en) | 2019-07-31 |
| PE20180577A1 (es) | 2018-04-04 |
| EP3329019A4 (en) | 2018-06-06 |
| AR105542A1 (es) | 2017-10-11 |
| MX2018001373A (es) | 2018-06-15 |
| RU2707549C2 (ru) | 2019-11-27 |
| BR112018002140B1 (pt) | 2024-01-23 |
| WO2017021814A1 (en) | 2017-02-09 |
| RU2018104707A (ru) | 2019-08-28 |
| US20180327843A1 (en) | 2018-11-15 |
| CN108368556A (zh) | 2018-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002364A1 (es) | Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas | |
| CL2018000813A1 (es) | Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso. | |
| CL2015002570A1 (es) | Anticuerpos humanos de la proteína f del virus respiratorio sincitial y métodos de uso de estos | |
| BR112016030968A2 (pt) | análogos de pridopidina, preparação e uso destes | |
| MA43108A (fr) | Anticorps neutralisant le virus syncytial respiratoire humain | |
| DOP2015000246A (es) | Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares | |
| BR112016020618A2 (pt) | oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido | |
| BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
| CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
| BR112016018549A2 (pt) | sistemas e métodos para cura de tecido | |
| DK3508209T3 (da) | Sammensætninger med et svækket newcastle sygdoms-virus og fremgangsmåder til anvendelse til behandling af neoplasi | |
| HK1256752A1 (zh) | 取代的苯並咪唑，它們的製備和它們作為藥物的用途 | |
| DK3179007T3 (da) | Justerbar glasskinnekonstruktion | |
| BR112018002140A2 (pt) | USO DE MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR ASGRAVIDADES DAS INFECÇÕES RESPIRATÓRIAS POR VÍRUS RESPIRATÓRIO SINCITIAL E METAPNEUMOVÍRUS HUMANO | |
| BR112015018674A2 (pt) | aparelho para o processamento de sequências de nucleotídeos, método para o processamento de sequências de nucleotídeos, e, uso do aparelho | |
| CL2016000998A1 (es) | Composición herbaria, procedimiento para su preparación y uso de la misma | |
| BR112018005299A2 (pt) | 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso | |
| ITUA20162350A1 (it) | Composizione per decolorare la fibra cheratinica | |
| ES2523418R2 (es) | Procedimiento de obtencion de composiciones protegidas para alimentacion animal, composiciones y uso de las mismas | |
| FR3004424B1 (fr) | Marchepied amovible d'aeronef, et aeronef | |
| ES2974003T3 (es) | Derivado de la formilpiridina con actividad inhibidora del FGFR4, método de preparación y uso del mismo | |
| BR112018006560A2 (pt) | composições para higiene bucal e métodos de uso das composições. | |
| BR112017014739A2 (pt) | produto absorvente descartável, produto absorvente descartável para uso por indivíduos com incontinência, e, método de composição de um produto absorvente | |
| CL2015003706A1 (es) | Composiciones vacunales bivalentes y su uso para la terapia de tumores | |
| ES1135907Y (es) | Dispositivo para la recogida y aprovechamiento del agua de lluvia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/07/2016, OBSERVADAS AS CONDICOES LEGAIS |